Real Time Medical Systems (Real Time), a healthcare interventional analytics solution, announced the closing of $20 million in a Series C funding round led by BASE Capital and SunBridge Capital.
The new investment will help advance interventional analytics software platforms and further accelerate market growth, the company said.
Real Time said its interventional analytics platform enhances care coordination and clinical decision-making through electronic health records data interoperability between post-acute care facilities and health systems, accountable care organizations, and payers.
According to the company, the interventional analytics platform also enables care teams to reduce hospital admission rates, detect early signs of infectious diseases, and improve patient outcomes throughout the continuum of care, using live clinical alerts coupled with recommended interventions.
The latest funds will advance product development, expand scalability, and extend the interventional analytics platform in post-acute interoperability.
“The healthcare industry is at a pivotal moment, which presents both significant challenges and tremendous opportunities,” states Dr. Scott Rifkin, Executive Chairman at Real Time. “This past year has shown that seamless care coordination and data interoperability are vital to improving patient care between varying clinical settings. This Series C investment will help us reach the next stage of growth to meet these challenges head-on while further partnering with our customers to advance our innovative solutions.”
“We continue to be impressed with Real Time’s management team and its commitment to improving care coordination through the company’s unique Interventional Analytics solution,” said Stephen Raggio, Chief Investment Officer, BASE Capital. “The company’s industry-leading technological and analytical advancements will be instrumental in helping providers and payers succeed in value-based care, and we are very excited to be a part of that solution.”
Healthcare Data Analytics companies secured $1.5 billion in venture capital funding in 33 funding rounds in the first half (1H) of 2021, a ~90% increase year-over-year, compared to $826 million raised in 35 funding rounds in 1H 2020, according to the recently released Mercom Digital Health Funding and M&A Report. Komodo Health, an AI-enabled data analytics software platform for healthcare providers, announced a $220 million Series E funding round.